Compare Japfa Comfeed Indonesia Tbk. (JPFA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Japfa Comfeed Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Japfa Comfeed Indonesia Tbk. trades at Rp2,030 (market cap 23.8T, 8.44M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Japfa Comfeed Indonesia Tbk. is far larger — about 142.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Japfa Comfeed Indonesia Tbk. is more actively traded (8.44M versus 96.7K). Which is the better fit depends on your goals.
| JPFA | OBAT | |
|---|---|---|
Market Cap | 23.8T | 167.37B |
Volume | 8.44M | 96.7K |
Lot | 84.36K | 967 |
Turnover | 17.08B | 23.82M |
Average Price | 2,024.41 | 246.34 |
Value | 17.08B | 23.82M |
Indicative Equilibrium Price | 2,030 | 248 |
Indicative Equilibrium Volume | 3.58K | 41 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Japfa Comfeed Indonesia Tbk.
PT Japfa Comfeed Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 based on Notarial Deed No. 59 dated January 18, 1971 of Djojo Muljadi, S.H., public notary, as amended by Notarial Deed No. 60 dated Februari 15, 1972, of the same notary. Japfa is currently the second largest animal feed producer in Indonesia with an estimated market share of around 35% in the domestic poultry feed market. The company was originally involved in the production of copra extraction pellets
Read more on JPFA →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
